Hallmarks of cancer: The insulin-like growth factors perspective.
IGF1 receptor (IGF1R)
apoptosis
cancer hallmarks
cell cycle
insulin-like growth factor-1 (IGF1)
p53
tumor suppressors
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
09
2022
accepted:
07
11
2022
entrez:
8
12
2022
pubmed:
9
12
2022
medline:
9
12
2022
Statut:
epublish
Résumé
The identification of a series of attributes or
Identifiants
pubmed: 36479090
doi: 10.3389/fonc.2022.1055589
pmc: PMC9720135
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1055589Informations de copyright
Copyright © 2022 Werner and LeRoith.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neuroreport. 1997 Jan 20;8(2):455-60
pubmed: 9080428
Endocrinol Metab Clin North Am. 2012 Jun;41(2):231-47, v
pubmed: 22682628
EMBO J. 1994 Jul 15;13(14):3286-95
pubmed: 8045259
Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7386-90
pubmed: 8346260
Br J Cancer. 1992 Mar;65(3):311-20
pubmed: 1313689
Oncogene. 2015 Apr 23;34(17):2227-38
pubmed: 24909165
F1000Res. 2020 Mar 23;9:
pubmed: 32226608
Front Cell Dev Biol. 2020 Dec 08;8:608412
pubmed: 33364239
Brain Res Mol Brain Res. 1993 Mar;17(3-4):347-50
pubmed: 7685464
Endocr Rev. 1992 Nov;13(4):641-69
pubmed: 1281087
Front Endocrinol (Lausanne). 2020 Jul 07;11:435
pubmed: 32733384
Clin Cancer Res. 2019 Jun 15;25(12):3479-3485
pubmed: 30745299
Lancet Oncol. 2012 Dec;13(12):e537-44
pubmed: 23182194
Nat Rev Mol Cell Biol. 2015 Jul;16(7):393-405
pubmed: 26122615
Cell Metab. 2020 Sep 1;32(3):353-365.e8
pubmed: 32726606
Neoplasia. 2018 Apr;20(4):387-400
pubmed: 29539586
Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):302-10
pubmed: 17315038
Cell. 1997 Feb 7;88(3):323-31
pubmed: 9039259
Front Endocrinol (Lausanne). 2022 May 27;13:895240
pubmed: 35692387
Front Endocrinol (Lausanne). 2014 May 19;5:76
pubmed: 24904527
Front Endocrinol (Lausanne). 2015 Apr 27;6:64
pubmed: 25964779
Mol Cell Biol. 1994 Jun;14(6):3604-12
pubmed: 8196606
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3921-6
pubmed: 18322014
Target Oncol. 2017 Oct;12(5):571-597
pubmed: 28815409
Curr Mol Med. 2006 Nov;6(7):739-48
pubmed: 17100600
Expert Opin Ther Targets. 2009 Oct;13(10):1179-92
pubmed: 19663648
J Biol Chem. 2012 Jan 20;287(4):2766-76
pubmed: 22128190
Expert Opin Investig Drugs. 2019 Dec;28(12):1101-1112
pubmed: 31731883
Cold Spring Harb Perspect Med. 2012 Dec 01;2(12):a006593
pubmed: 23209176
Cell. 1993 Oct 8;75(1):73-82
pubmed: 8402902
J Cell Physiol. 2013 Apr;228(4):675-9
pubmed: 22926508
N Engl J Med. 1993 Oct 28;329(18):1318-27
pubmed: 8413413
Cancer Res. 2018 Jul 1;78(13):3497-3509
pubmed: 29735545
J Mol Endocrinol. 2018 Jul;61(1):T115-T137
pubmed: 29626053
Drug Discov Today. 2005 Aug 1;10(15):1041-7
pubmed: 16055020
Oncology. 2002;63(4):317-32
pubmed: 12417786
Endocr Relat Cancer. 2011 Jul 04;18(4):R125-47
pubmed: 21606157
Trends Endocrinol Metab. 2006 Aug;17(6):236-42
pubmed: 16815029
Cell. 1996 Aug 9;86(3):353-64
pubmed: 8756718
Cancer Res. 1995 Jan 15;55(2):249-52
pubmed: 7812953
J Cell Biol. 2001 Jul 23;154(2):447-58
pubmed: 11470831
J Pathol. 2011 Dec;225(4):475-8
pubmed: 22025211
Cells. 2019 Aug 14;8(8):
pubmed: 31416218
Breast Cancer Res Treat. 2012 Feb;132(1):131-42
pubmed: 21574055
Cells. 2019 Oct 06;8(10):
pubmed: 31590432
Oncogene. 1999 Dec 13;18(53):7644-55
pubmed: 10618704
Oncogene. 2007 Oct 4;26(45):6499-508
pubmed: 17486080
Front Endocrinol (Lausanne). 2022 Apr 21;13:892140
pubmed: 35528015
Biochim Biophys Acta. 1997 Jun 7;1332(3):F105-26
pubmed: 9196021
Mol Cell Endocrinol. 2013 Jul 15;374(1-2):101-7
pubmed: 23643895
Nat Rev Drug Discov. 2002 Oct;1(10):769-83
pubmed: 12360255
Int J Oncol. 2008 Jan;32(1):41-8
pubmed: 18097541
J Lab Clin Med. 1957 Jun;49(6):825-36
pubmed: 13429201
Endocrinol Metab Clin North Am. 2012 Jun;41(2):249-63, v
pubmed: 22682629
Clin Cancer Res. 2006 Aug 1;12(15):4755-65
pubmed: 16899627
Cancer Cell. 2003 Apr;3(4):311-6
pubmed: 12726857
Nat Rev Cancer. 2002 Jan;2(1):38-47
pubmed: 11902584
Adv Cancer Res. 2002;85:1-12
pubmed: 12374282
Oncogenesis. 2020 Jul 29;9(7):69
pubmed: 32728020
Cancer Metastasis Rev. 2022 Sep;41(3):463-464
pubmed: 35804203
Sci Signal. 2010 Feb 09;3(108):ra10
pubmed: 20145208
J Biol Chem. 2013 Mar 8;288(10):6835-48
pubmed: 23329835
Nat Med. 2004 Aug;10(8):789-99
pubmed: 15286780
Oncotarget. 2020 Apr 28;11(17):1515-1530
pubmed: 32391121
Mol Genet Metab. 2000 Feb;69(2):130-6
pubmed: 10720440
Mol Genet Metab. 2000 Sep-Oct;71(1-2):315-20
pubmed: 11001824
Nat Rev Cancer. 2004 Aug;4(8):579-91
pubmed: 15286738
Eur J Cancer. 2020 Dec;141:115-127
pubmed: 33130549
Novartis Found Symp. 2004;262:160-71; discussion 171-6, 265-8
pubmed: 15562828
Trends Mol Med. 2006 Apr;12(4):177-85
pubmed: 16530485
Endocr Rev. 2001 Feb;22(1):53-74
pubmed: 11159816
Cancer Res. 2002 May 15;62(10):2942-50
pubmed: 12019176
Neurobiol Dis. 1997;4(3-4):201-14
pubmed: 9361296
J Neural Transm Suppl. 2000;(60):261-72
pubmed: 11205145
Horm Cancer. 2018 Jun;9(3):205-214
pubmed: 29524179
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11217-21
pubmed: 8248231
Cancer Res. 1995 Sep 1;55(17):3739-41
pubmed: 7641185
J Biol Chem. 1994 Nov 4;269(44):27315-21
pubmed: 7525552
Cell Mol Life Sci. 2014 Jul;71(13):2403-27
pubmed: 24276851
J Clin Endocrinol Metab. 1992 Sep;75(3):962-8
pubmed: 1381376
J Clin Invest. 1989 Aug;84(2):619-26
pubmed: 2547834
Cell. 1994 Dec 16;79(6):927-30
pubmed: 8001140
Genes Dev. 1998 Aug 1;12(15):2245-62
pubmed: 9694791
J Immunol. 2000 Jun 15;164(12):6287-95
pubmed: 10843682
Arch Biochem Biophys. 2002 Mar 15;399(2):212-24
pubmed: 11888208
Physiol Rev. 2015 Jul;95(3):727-48
pubmed: 26084689
Nat Rev Cancer. 2010 Apr;10(4):232-3
pubmed: 20355252
Cancer Treat Rev. 2014 Oct;40(9):1096-105
pubmed: 25123819
Cell. 1995 May 5;81(3):323-30
pubmed: 7736585
Mol Cell Biol. 1997 Mar;17(3):1084-92
pubmed: 9032235
Brain Res. 1991 Sep 27;560(1-2):167-74
pubmed: 1722132
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8247-52
pubmed: 12821780
Endocrinology. 1997 Jul;138(7):3024-34
pubmed: 9202248
Mol Cell Endocrinol. 2006 Jun 27;252(1-2):241-6
pubmed: 16647191
Expert Opin Ther Targets. 2013 Mar;17(3):307-20
pubmed: 23294364
Pediatr Endocrinol Rev. 2018 Sep;16(Suppl 1):39-62
pubmed: 30378782
Development. 2007 Jul;134(13):2501-9
pubmed: 17537792
Endocrinology. 2013 May;154(5):1672-9
pubmed: 23507573
Cell. 1993 Oct 8;75(1):59-72
pubmed: 8402901
Pediatr Endocrinol Rev. 2004 Jun;1(4):352-60
pubmed: 16437028
Oncogene. 2000 Dec 11;19(53):6152-8
pubmed: 11156529
Clin Cancer Res. 2016 Jun 15;22(12):2897-907
pubmed: 26831715
FEBS Lett. 2003 Apr 24;541(1-3):149-54
pubmed: 12706836
Cancer Res. 2004 Apr 1;64(7):2627-33
pubmed: 15059920
Trends Endocrinol Metab. 2008 Aug;19(6):197-205
pubmed: 18515143
Endocr Rev. 1996 Oct;17(5):481-517
pubmed: 8897022
Proc Natl Acad Sci U S A. 1992 May 1;89(9):3889-93
pubmed: 1570309
Cancer Res. 1998 Jun 1;58(11):2477-84
pubmed: 9622092
J Endocrinol. 2006 Dec;191(3):605-12
pubmed: 17170218
Biochim Biophys Acta. 1994 Sep 13;1219(1):26-32
pubmed: 8086474
Lancet. 2004 Apr 24;363(9418):1346-53
pubmed: 15110491
Front Oncol. 2016 Jun 23;6:159
pubmed: 27446805
J Biol Chem. 2006 Aug 4;281(31):21884-21891
pubmed: 16766796
PLoS One. 2017 Sep 25;12(9):e0185164
pubmed: 28945762
Cancer Res. 1995 Jun 1;55(11):2463-9
pubmed: 7758000
Nat Genet. 1996 Mar;12(3):298-302
pubmed: 8589721
Science. 1994 Oct 7;266(5182):120-2
pubmed: 7939630
Cancer Res. 1990 Apr 15;50(8):2511-7
pubmed: 2156621
Oncogene. 2022 Jan;41(4):600-611
pubmed: 34785779
J Neurosci Methods. 2019 May 1;319:40-46
pubmed: 30412730
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1045-1050
pubmed: 29339473
Mol Endocrinol. 2015 Nov;29(11):1549-57
pubmed: 26366975
Dev Biol. 2020 Jul 1;463(1):77-87
pubmed: 32376245
Dev Biol. 2001 Jan 1;229(1):141-62
pubmed: 11133160
Horm Metab Res. 2003 Nov-Dec;35(11-12):758-62
pubmed: 14710355
BMC Med. 2010 Jan 05;8:2
pubmed: 20051101
J Biol Chem. 1997 Nov 21;272(47):29438-41
pubmed: 9368001
Curr Oncol. 2008 Aug;15(4):188-92
pubmed: 18769612
Sci Signal. 2020 May 26;13(633):
pubmed: 32457114
Oncogene. 2012 May 31;31(22):2703-14
pubmed: 21963847
Mol Cell Biol. 1997 Jan;17(1):427-35
pubmed: 8972223
Annu Rev Cell Dev Biol. 1999;15:551-78
pubmed: 10611972
Nucleic Acids Res. 2002 Apr 15;30(8):1859-67
pubmed: 11937641
Cancer Res. 1991 Nov 1;51(21):5997-6000
pubmed: 1657376
Front Endocrinol (Lausanne). 2015 Apr 24;6:59
pubmed: 25964777
Br J Cancer. 2017 Dec 5;117(12):1777-1786
pubmed: 29123263
Breast Cancer Res. 2017 Dec 6;19(1):129
pubmed: 29212519
Mol Genet Metab. 2019 Mar;126(3):259-265
pubmed: 30639046
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Antioxid Redox Signal. 2012 Mar 15;16(6):587-96
pubmed: 21929372
Cell Death Differ. 2013 May;20(5):774-83
pubmed: 23412343
Growth Horm IGF Res. 2010 Feb;20(1):68-72
pubmed: 19703789
Endocr Rev. 1995 Feb;16(1):3-34
pubmed: 7758431
Nature. 2007 Aug 30;448(7157):1015-21
pubmed: 17625568
J Biol Chem. 2002 Oct 11;277(41):38205-11
pubmed: 12149254
Sci Rep. 2020 Feb 11;10(1):2309
pubmed: 32047176
Phys Biol. 2016 May 11;13(3):031001
pubmed: 27172135
Endocr Relat Cancer. 2006 Jun;13(2):279-92
pubmed: 16728564
Genes Dev. 2001 Feb 1;15(3):267-85
pubmed: 11159908
Front Endocrinol (Lausanne). 2022 Jun 17;13:911079
pubmed: 35784559
J Clin Invest. 1988 Sep;82(3):950-7
pubmed: 3262126
Cell Mol Life Sci. 2000 Jun;57(6):932-42
pubmed: 10950308
Mol Endocrinol. 1991 May;5(5):718-24
pubmed: 1649394
Science. 1998 Aug 28;281(5381):1309-12
pubmed: 9721092
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Science. 1994 Oct 7;266(5182):66-71
pubmed: 7545954
FASEB J. 1992 Oct;6(13):3169-76
pubmed: 1397838
Nature. 1994 Jun 2;369(6479):414-8
pubmed: 7910953
J Natl Cancer Inst. 2012 Jul 3;104(13):975-81
pubmed: 22761272
Clin Cancer Res. 2009 Mar 1;15(5):1558-65
pubmed: 19223505
EMBO Rep. 2012 Mar 01;13(3):244-50
pubmed: 22261717
Science. 1993 Jan 1;259(5091):94-7
pubmed: 8418502
Exp Cell Res. 2006 Mar 10;312(5):594-607
pubmed: 16376330
Endocr Rev. 1995 Apr;16(2):143-63
pubmed: 7540132
Front Cell Dev Biol. 2020 Nov 16;8:599281
pubmed: 33304904
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8318-23
pubmed: 8710868
Mol Cell Endocrinol. 2020 Dec 1;518:111003
pubmed: 32919021
Pathol Oncol Res. 2018 Jul;24(3):679-688
pubmed: 28842827
Nat Rev Cancer. 2014 May;14(5):359-70
pubmed: 24739573
Cells. 2021 Aug 12;10(8):
pubmed: 34440832
Front Endocrinol (Lausanne). 2014 Feb 04;5:10
pubmed: 24550888
Biomolecules. 2020 Dec 15;10(12):
pubmed: 33333800
Cancer Cell. 2004 Mar;5(3):201-2
pubmed: 15050909
Science. 1991 Jun 21;252(5013):1708-11
pubmed: 2047879
J Biol Chem. 2002 May 3;277(18):15600-6
pubmed: 11877395
J Mol Endocrinol. 2018 Jul;61(1):T45-T60
pubmed: 29273680
Cancer Res. 2010 Aug 15;70(16):6412-9
pubmed: 20710042
Pediatr Endocrinol Rev. 2008 Feb;5 Suppl 2:739-43
pubmed: 18317445
Int J Cancer. 2000 Nov 20;89(6):506-13
pubmed: 11102895
Ann N Y Acad Sci. 1997 Dec 29;833:137-46
pubmed: 9616746
Antioxid Redox Signal. 2000 Spring;2(1):83-92
pubmed: 11232604
EMBO J. 1998 Sep 1;17(17):5085-94
pubmed: 9724644
Cells. 2020 Nov 09;9(11):
pubmed: 33182502